IOLCPPharmaceuticals
IOL Chemicals and Pharmaceuticals Ltd — Cash Flow Statement
₹72.77
-0.81%
IOL Chemicals and Pharmaceuticals Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| End Cash Position | 78.17 Cr | 7.69 Cr | 1.39 Cr | 3.23 Cr | — |
| Beginning Cash Position | 7.69 Cr | 1.39 Cr | 3.23 Cr | 32.34 Cr | — |
| Changes In Cash | 70.48 Cr | 6.30 Cr | -1.84 Cr | -29.11 Cr | — |
| Financing Cash Flow | 46.04 Cr | -92.50 Cr | -4.11 Cr | -1.64 Cr | — |
| Interest Paid Cff | -14.76 Cr | -16.10 Cr | -16.40 Cr | -8.11 Cr | — |
| Cash Dividends Paid | -23.48 Cr | -29.35 Cr | -23.50 Cr | -35.22 Cr | — |
| Common Stock Dividend Paid | -23.48 Cr | -29.35 Cr | -23.50 Cr | -35.22 Cr | — |
| Net Issuance Payments Of Debt | 84.28 Cr | -46.87 Cr | 36.88 Cr | 42.75 Cr | — |
| Net Short Term Debt Issuance | 84.28 Cr | -46.87 Cr | 36.88 Cr | 42.75 Cr | — |
| Investing Cash Flow | -154.18 Cr | -190.98 Cr | -120.00 Cr | -120.52 Cr | — |
| Net Other Investing Changes | 0.15 Cr | 0.09 Cr | -8.36 Cr | -10.13 Cr | — |
| Interest Received Cfi | 12.33 Cr | 13.48 Cr | 17.73 Cr | 18.60 Cr | — |
| Net Investment Purchase And Sale | 45.91 Cr | 67.77 Cr | 80.23 Cr | 22.41 Cr | — |
| Sale Of Investment | 45.91 Cr | 68.01 Cr | 97.84 Cr | 23.55 Cr | — |
| Purchase Of Investment | 0.00 | -0.24 Cr | -17.61 Cr | -1.14 Cr | — |
| Net PPE Purchase And Sale | -212.57 Cr | -272.32 Cr | -209.60 Cr | -151.40 Cr | — |
| Sale Of PPE | 0.98 Cr | 1.85 Cr | 2.22 Cr | 1.89 Cr | — |
| Purchase Of PPE | -213.55 Cr | -274.17 Cr | -211.82 Cr | -153.29 Cr | — |
| Operating Cash Flow | 178.62 Cr | 289.78 Cr | 122.27 Cr | 93.05 Cr | — |
| Taxes Refund Paid | -18.32 Cr | -42.02 Cr | -47.10 Cr | -62.58 Cr | — |
| Change In Working Capital | -20.87 Cr | 90.33 Cr | -63.69 Cr | -102.34 Cr | — |
| Change In Payable | -46.05 Cr | 161.99 Cr | -104.99 Cr | 183.19 Cr | — |
| Change In Inventory | 64.22 Cr | -99.32 Cr | 84.37 Cr | -114.75 Cr | — |
| Change In Receivables | -39.04 Cr | 27.66 Cr | -43.07 Cr | -170.78 Cr | — |
| Other Non Cash Items | 4.15 Cr | 1.95 Cr | -0.33 Cr | -9.93 Cr | — |
| Depreciation And Amortization | 71.99 Cr | 62.91 Cr | 46.16 Cr | 43.26 Cr | — |
| Depreciation | 71.99 Cr | 62.91 Cr | 46.16 Cr | 43.26 Cr | — |
| Gain Loss On Investment Securities | -0.43 Cr | -0.33 Cr | -0.01 Cr | -0.02 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 3.88 Cr | -4.77 Cr | -1.97 Cr | -1.28 Cr | — |
| Gain Loss On Sale Of PPE | 0.18 Cr | -0.10 Cr | 0.59 Cr | 1.09 Cr | — |
| Net Income From Continuing Operations | 137.96 Cr | 181.65 Cr | 188.65 Cr | 224.85 Cr | — |
| Free Cash Flow | -34.93 Cr | 15.61 Cr | -89.55 Cr | -60.24 Cr | — |
| Capital Expenditure | -213.55 Cr | -274.17 Cr | -211.82 Cr | -153.29 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | — | — | 0.10 Cr | — |
| Net Long Term Debt Issuance | — | — | — | 42.75 Cr | -0.07 Cr |
| Long Term Debt Issuance | — | — | — | 42.75 Cr | — |
| Issuance Of Debt | — | — | — | 42.75 Cr | — |
| Net Common Stock Issuance | — | — | — | — | 27.95 Cr |
| Common Stock Issuance | — | — | — | — | 27.95 Cr |
| Short Term Debt Payments | — | — | — | — | -55.92 Cr |
| Long Term Debt Payments | — | — | — | — | -0.07 Cr |
| Repayment Of Debt | — | — | — | — | -55.99 Cr |
| Issuance Of Capital Stock | — | — | — | — | 27.95 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on IOL Chemicals and Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.